<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Occupancy of α7 Nicotinic Acetylcholine Receptors in the Brain by Tropisetron: A Positron Emission Tomography Study Using [ 11 C]CHIBA-1001 in Healthy Human Subjects</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Kenji</forename><surname>Hashimoto</surname></persName>
							<email>hashimoto@faculty.chiba-u.jp</email>
							<affiliation key="aff1">
								<orgName type="department">Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health</orgName>
								<address>
									<settlement>Chiba</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masatomo</forename><surname>Ishikawa</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health</orgName>
								<address>
									<settlement>Chiba</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Muneyuki</forename><surname>Sakata</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Positron Medical Center</orgName>
								<orgName type="department" key="dep2">Tokyo Metropolitan Institute of Gerontology</orgName>
								<address>
									<settlement>Tokyo</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Toyohara</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Positron Medical Center</orgName>
								<orgName type="department" key="dep2">Tokyo Metropolitan Institute of Gerontology</orgName>
								<address>
									<settlement>Tokyo</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keiichi</forename><surname>Oda</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Positron Medical Center</orgName>
								<orgName type="department" key="dep2">Tokyo Metropolitan Institute of Gerontology</orgName>
								<address>
									<settlement>Tokyo</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Ishii</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Positron Medical Center</orgName>
								<orgName type="department" key="dep2">Tokyo Metropolitan Institute of Gerontology</orgName>
								<address>
									<settlement>Tokyo</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin</forename><surname>Wu</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health</orgName>
								<address>
									<settlement>Chiba</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Taisuke</forename><surname>Yoshida</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health</orgName>
								<address>
									<settlement>Chiba</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Psychiatry, Chiba University Graduate School of Medicine</orgName>
								<address>
									<settlement>Chiba</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaomi</forename><surname>Iyo</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Psychiatry, Chiba University Graduate School of Medicine</orgName>
								<address>
									<settlement>Chiba</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kiichi</forename><surname>Ishiwata</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Positron Medical Center</orgName>
								<orgName type="department" key="dep2">Tokyo Metropolitan Institute of Gerontology</orgName>
								<address>
									<settlement>Tokyo</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Division of Clinical Neuroscience</orgName>
								<orgName type="institution">Chiba University Center for Forensic Mental Health</orgName>
								<address>
									<addrLine>1-8-1 Inohana</addrLine>
									<postCode>260-8670</postCode>
									<settlement>Chiba</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Occupancy of α7 Nicotinic Acetylcholine Receptors in the Brain by Tropisetron: A Positron Emission Tomography Study Using [ 11 C]CHIBA-1001 in Healthy Human Subjects</title>
					</analytic>
					<monogr>
						<idno type="ISSN">p 1738-1088</idno>
					</monogr>
					<note type="submission">Received: June 13, 2011 / Revised: August 24, 2011 Accepted: September 6, 2011</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T22:35+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>α7-nicotinic acetylcholine receptor</term>
					<term>Positron-emission tomography</term>
					<term>Tropisetron</term>
					<term>Ondansetron</term>
					<term>[ 11 C]CHIBA-1001</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Objective: Agonists of α7-nicotinic acetylcholine receptors (nAChRs) have been developed as potential therapeutic drugs for neuropsychiatric diseases such as schizophrenia and Alzheimer&apos;s disease. Positron emission tomography (PET) is a noninvasive brain imaging technique to measure receptor occupancy in the living human brain. Although much effort has been expended to create specific PET radioligands for α7-nAChRs in the brain, only 4-[ 11 C]methylphenyl-1,4-diazabicyclo[3.2.2.]nonane-4-carboxylate ([ 11 C]CHIBA-1001) is currently available for clinical studies. In contrast, two 5-hydroxytryptamine-3 (5-HT3) receptor antagonists, tropisetron and ondansetron, have been used to treat patients with chemotherapy-induced or postoperative nausea and vomiting. Furthermore, tropisetron, but not ondansetron, possesses high affinity for α7-nAChRs. In the present study, we evaluated the receptor occupancy in the human brain after a single oral administration of tropisetron and ondansetron using [ 11 C]CHIBA-1001 and PET. Methods: Two serial dynamic PET scans using [ 11 C]CHIBA-1001 in healthy non-smoking male subjects were performed before and after receiving an oral administration of these medications. Results: A single oral administration of tropisetron, but not ondansetron, decreased the total distribution volume of [ 11 C]CHIBA-1001 in the human brain. Conclusion: This study shows that tropisetron, but not ondansetron, could bind to α7-nAChRs in the human brain after a single oral administration. Therefore, [ 11 C]CHIBA-1001 may be a useful PET radioligand to measure the occupancy of α7-nAChRs in the human brain.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>The main subtypes of nicotinic acetylcholine receptors (nAChRs) in the central nervous system are the α4β2 and α7 subtypes. α7-nAChRs have lower affinity for acetylcholine compared with α4β2 nAChRs <ref type="bibr" target="#b0">1)</ref> and demonstrate a high capacity for calcium influx that equals or exceeds N-methyl-D-aspartate receptors, suggesting its significant role in regulating a variety of downstream signaling events.</p><p>2) Accumulating evidence suggests that α7-nAChRs play a role in the pathophysiology of several neu-ropsychiatric diseases such as schizophrenia, Alzheimer's disease, attention deficit hyperactivity disorder, and Parkinson's disease. <ref type="bibr">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref> A number of pharmaceutical programs have been developing selective agonists and positive allosteric modulators of α7-nAChRs <ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref> as potential therapeutic drugs for these diseases. However, it is difficult to evaluate the potential dose regimens of these drugs for treating these diseases. Positron emission tomography (PET) is one of the brain imaging techniques that can measure biochemical and physiological information in the living human brain. The distribution and density of receptors in the living human brain can be visualized noninvasively by PET using receptor-specific radioligands, and the receptor-radioligand binding can be quantified by appropriate tracer kinetic models. <ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b16">17)</ref> Much effort has been devoted to visualize α7-nAChRs in the human brain by PET, but the development of specific radioligands that depict α7-nAChRs has been hampered by the relatively low levels of α7-nAChRs in the brain. <ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref> Generally, α-bungarotoxin and methyllycaconitine (MLA) are well known to be specific and potent α7-nAChR antagonists, but due to their large molecular weights, they have difficulty passing through the blood-brain barrier, which makes them unfavorable as PET radioligands. <ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b23">[23]</ref> Consequently, a number of compounds have been developed and evaluated as potential PET radioligands for α7-nAChRs. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b25">24)</ref> However, only Potent 5-hydroxytryptamine-3 (5-HT 3 ) receptor antagonists such as tropisetron and ondansetron have been used to treat patients with chemotherapy-induced or postoperative nausea and vomiting. <ref type="bibr" target="#b29">[28]</ref><ref type="bibr" target="#b30">[29]</ref><ref type="bibr" target="#b32">[30]</ref> Tropisetron is a partial agonist of α7-nAChRs with high affinity (Ki=6.9 nM), whereas ondansetron has low affinity for α7-nAChRs (Ki＞10,000 nM) ( <ref type="table" target="#tab_0">Table 1)</ref>. <ref type="bibr" target="#b33">31,</ref><ref type="bibr" target="#b34">32)</ref> Both drugs lack affinity for α4β2-nAChRs <ref type="table" target="#tab_0">(Table 1</ref>). In the present study, we investigated whether a single administration of tropisetron or ondansetron would bind to α7-nAChRs in the intact human brain using [ 11 C]CHIBA-1001 and PET.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Subjects</head><p>This study was approved by the Ethics Committees of Tokyo Metropolitan Institute of Gerontology (Tokyo, Japan) and Chiba University Graduate School of Medi-cine (Chiba, Japan). Twelve healthy non-smoking male volunteers participated in the study (mean age, 22.2 years; SD, 3.0; range, 20-31). Written informed consent was obtained from each subject after the procedures had been fully explained. None of the subjects had any neurological or psychological findings, and none showed any abnormalities on the brain magnetic resonance imaging scan taken between the two PET scans. None had been receiving any medications of any kind, and none had a history of alcoholism. ]CHIBA-1001-PET scans, one before and one after oral administration of tropisetron or ondansetron. The second PET scan took place 3-3.5 hours after taking the medication to coincide with the peak plasma level. After oral administration of a single dose of tropisetron (5 mg), blood concentration reaches a peak in approximately 3.4 hours in healthy Japanese male subjects. 33) Accordingly, we collected venous blood samples (except from one volunteer for technical reasons) just before tracer injection of the second PET scan to monitor the tropisetron concentration. Plasma tropisetron concentration was measured by high performance liquid chromatography (HPLC) followed by tandem mass spectrometry. In the case of ondansetron, the second PET scan occurred 2 hours after administration, as the concentration in blood reaches its peak in approximately 2 hours after oral administration of a single dose of ondansetron (4 mg) in healthy Japanese male subjects. <ref type="bibr" target="#b36">34)</ref> Volunteers were randomly administered either tropisetron (5, 10, or 20 mg, n=3 for each dose; Navoban Ⓡ , Novartis Pharma KK, Tokyo, Japan) or ondansetron (8 mg, n=3; Zofran Ⓡ , GlaxoSmithKline KK, Tokyo, Japan). PET was performed at the Positron Medical Center, Tokyo Metropolitan Institute of Gerontology with a SET 2400W scanner (Shimadzu Co., Kyoto, Japan). <ref type="bibr" target="#b37">35)</ref> The spatial resolution was 4.4 mm full width at half maximum in the transverse direction and 6.5 mm full width at half maximum in the axial direction. A transmission scan was performed with a rotating 68 Ga/ 68 Ge rod source for 5 minutes for attenuation correction before the administration of [ 11 C]CHIBA-1001, which was prepared as described previously. <ref type="bibr" target="#b26">25)</ref> A dynamic series of decay-corrected PET data acquisition data were collected in the two-dimensional mode for 90 minutes starting at the time of the intravenous bolus injection of [ 11 C]CHIBA-1001 (injected dose, 518±53 MBq; specific activity, 42.7±22.6 TBq/mmol). The frame arrangement was 10 seconds×6 frames, 30 seconds×3 frames, 60 seconds×5 frames, 150 seconds×5 frames, and 300 seconds×14 frames. The dynamic image was reconstructed with a filtered back-projection algorithm using a Butterworth filter (1.25 cycles/cm, order 2); the image matrix was 128×128×31, and the voxel size was 2×2×6.25 mm. Each subject was placed in a supine position with eyes closed. Immediately after the bolus injection, 12 arterial blood samples were collected at 10-second intervals over 2 minutes, and the remaining 14 samples were collected at longer intervals, for a total of 26 samples. All samples were manually drawn. Plasma was separated, weighed and measured for radioactivity with a sodium-iodide well scintillation counter. Six samples collected at 3, 10, 20, 30, 40, and 60 minutes were further processed by HPLC for metabolite analysis. <ref type="bibr" target="#b26">25)</ref> Data Analysis</p><p>Image manipulations were performed using the "Dr. View", version 5.2 medical image processing application package (AJS Inc., Tokyo, Japan). Regions of interest (ROIs) were defined over the frontal, temporal, parietal, and occipital cortices, head of the caudate nucleus, putamen, and cerebellum with reference to a coregistered magnetic resonance image, which served as an anatomical guide. The total distribution volume (VT) of [ 11 C]CHIBA-1001 was calculated from the regional time-activity curve and the metabolite-corrected input function using Logan graphical analysis. <ref type="bibr" target="#b38">36,</ref><ref type="bibr" target="#b39">37)</ref> Blocking rates (%) by tropisetron or ondansetron were calculated for each ROI as 100×[(V T at baseline−V T at loading)/V T at baseline]%.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p>Representative V T images of [ 11 C]CHIBA-1001 before and after tropisetron (20 mg) and ondansetron (8 mg) loading are shown in <ref type="figure" target="#fig_1">Fig. 1</ref>. Radioactivity in the human brain after intravenous administration of [ 11 C]CHIBA-1001 was widely distributed throughout, consistent with our previous report using postmortem human brain tissues. <ref type="bibr" target="#b40">38)</ref> A single administration of 20 mg tropisetron decreased the VT of [ 11 C] CHIBA-1001 in the brain <ref type="figure" target="#fig_1">(Fig. 1)</ref>, whereas ondansetron (8 mg) had no effect. The mean blocking rates of the whole brain by 5 mg, 10 mg, and 20 mg tropisetron were 1.2±0.02% (mean±SD, n=3), 7.6 ±0.03% (n=3), and 14.1±0.02% (n=3), respectively. In contrast, the mean blocking rate of ondansetron of the whole brain was −0.4±0.03% (n=3). As shown in <ref type="figure" target="#fig_2">Fig. 2</ref>, single administration of tropisetron blocked the binding of [ 11 C]CHIBA-1001 in the human brain in a dose-dependent manner, whereas a single administration of ondansetron had almost no effect. Furthermore, a significant (r= 0.979, p＜0.001) positive correlation was observed between the plasma concentration of tropisetron and the administered dose of tropisetron <ref type="figure">(Fig. 3)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>The present study showed that a single oral administration of tropisetron, but not ondansetron, blocks the binding of [ 11 C]CHIBA-1001 in the human brain in a dose-dependent manner.   <ref type="figure">. 3</ref>. Correlations between the administered dose of tropisetron and the plasma concentration of tropisetron. There is a significant (r=0.979, p＜0.001) positive correlation between the administered dose of tropisetron and plasma concentration. Plasma samples were taken 3-3.5 hours after administration of tropisetron.</p><p>Deficient inhibitory processing of the P50 auditory-evoked potential is a pathophysiological feature of schizophrenia. Several lines of evidence suggest that α7nicotinic receptors play a critical role in this phenomenon. Previously, we reported that tropisetron improved deficient auditory inhibition processing in DBA/2 mice and that the improvement by tropisetron could be antagonized by co-administration of the α7-nAChR antagonist MLA. <ref type="bibr" target="#b42">39)</ref> Furthermore, we also reported that phencyclidine (PCP)induced cognitive deficits in mice improve by subsequent subchronic administration of tropisetron, but not ondansetron, and that the improvement was antagonized by co-administration of MLA. <ref type="bibr" target="#b43">40)</ref> These preclinical findings suggest that tropisetron could improve abnormal auditory sensory gating and PCP-induced cognitive deficits in mice via α7-nAChRs. <ref type="bibr" target="#b42">39,</ref><ref type="bibr" target="#b43">40)</ref> In clinical studies, we reported that a single oral administration of tropisetron (10 mg) improved deficits in P50 suppression in non-smoking patients with schizophrenia. <ref type="bibr" target="#b44">41)</ref> A recent randomized, placebo-controlled study of tropisetron showed that tropisetron (10 mg/day for 8 weeks) significantly improved auditory sensory gating P50 deficits and attentional deficits in non-smoking patients with schizophrenia. <ref type="bibr" target="#b45">42)</ref> Taken together with these previous findings, the present study shows that tropisetron may bind to α7-nAChRs in the human brain after a single oral administration, suggesting the role of α7-nAChRs in the mechanisms of its efficacy. Of all ROIs, the highest blocking rate, approximately 22.6%, was seen in the cerebellum by 20 mg of tropi-setron. The dose-blocking rate relationship of tropisetron did not follow the simplified Hill equation of occupancy =Occupancy max [F/(F＋ED 50 )], where Occupancy max refers to maximal occupancy, F is dose or plasma concentration of tropisetron, and ED50 is the plasma tropisetron level resulting in 50% maximal occupancy. This suggests that 20 mg of tropisetron is not sufficient to saturate the blocking of [ 11 C]CHIBA-1001. Increasing the dose of tropisetron may reveal higher blocking rates, but we avoided this for safety reasons. The dose of ondansetron was limited to 8 mg due to the same safety reasons.</p><p>[ 11 C]CHIBA-1001 PET data were well described with a one-tissue two-compartment model, but the direct derivation of the specific binding potential (BPND) as BPND=k3/ k 4 in a two-tissue three-compartment model was unstable (data not shown). Furthermore, as the radioactivity after administration of [ 11 C]CHIBA-1001 was widely distributed throughout the human brain, there was no reference region for the indirect derivation of BP ND . Therefore, we used VT for quantitative analysis of [</p><p>11 C]CHIBA-1001</p><p>PET data in this study. Although CHIBA-1001 is devoid of activity (inhibition lower than 50%) for the 28 standard receptor-binding profile, <ref type="bibr" target="#b28">27)</ref> we recently reported that the non-specific binding of [ 3 H]CHIBA-1001 is relatively high in membranes from postmortem human brain samples. <ref type="bibr" target="#b40">38)</ref> In the present study, the exact occupancy of α7-nAChR by tropisetron could not be determined because V T , which is used for quantitative analysis of [ 11 C]CHIBA-1001 PET data, includes both specific and nonspecific binding. Despite these limitations, this study suggests that [ 11 C]CHIBA-1001 may be a useful PET ligand for blocking studies of α7-nAChR drugs in the human brain, particularly because more suitable PET ligands for human study are not currently available.</p><p>In conclusion, the present study showed that a single oral administration of tropisetron, but not ondansetron, blocked the binding of [ 11 C]CHIBA-1001 in the human brain and also suggests that [</p><p>11 C]CHIBA-1001 may be a useful PET ligand for blocking studies of α7-nAChRs in the human brain, although <ref type="bibr">[ 11 C]</ref>CHIBA-1001 exhibits a high level of non-specific binding in the human brain. Therefore, the development of novel PET ligands with low non-specific binding will be necessary.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>[ 11 C</head><label>11</label><figDesc>]CHIBA-1001 and PET Each volunteer participated in two [ 11 C</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 1 .</head><label>1</label><figDesc>Total distribution volume (VT) images of [ 11 C]CHIBA-1001 positron emission tomography before and after single oral administration of tropisetron or ondansetron. The upper pair represents VT images at baseline (left) and at tropisetron (20 mg)-loading (right) in the same subject. The lower pair shows VT images at baseline (left) and ondansetron (8 mg)-loading (right) in another subject.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 2 .</head><label>2</label><figDesc>Blocking rates of [ 11 C]CHIBA-1001 by tropisetron and ondansetron. The mean±standard deviation of three subjects for each dose is shown.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig</head><label></label><figDesc>Fig. 3. Correlations between the administered dose of tropisetron and the plasma concentration of tropisetron. There is a significant (r=0.979, p＜0.001) positive correlation between the administered dose of tropisetron and plasma concentration. Plasma samples were taken 3-3.5 hours after administration of tropisetron.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>Affinities of tropisetron and ondansetron at 5-HT3 receptors, α7-nAChRs, and α4β2nAChRs</figDesc><table><row><cell>Drugs</cell><cell>Ki for 5-HT3 receptors</cell><cell>Ki for α7-nAChRs</cell><cell>Ki for α4β2nAChRs</cell></row><row><cell></cell><cell>5.3 nM</cell><cell>6.9 nM</cell><cell>55,000 nM</cell></row><row><cell></cell><cell>12 nM</cell><cell>＞10,000 nM</cell><cell>46,000 nM</cell></row><row><cell cols="2">Data are from Reference. 31)</cell><cell></cell><cell></cell></row></table><note></note></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0" />
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The fall and rise of neuronal α-bungarotoxin binding proteins</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">B</forename><surname>Clarke</surname></persName>
		</author>
		<idno type="DOI">10.1016/0165-6147(92)90125-p</idno>
		<idno type="PMID">1332232</idno>
		<idno type="PII">0165-6147(92)90125-P</idno>
		<idno type="ark">ark:/67375/6H6-S6MR5FCM-8</idno>
		<idno type="istexId">71A2D6DD0732EB20809463C588CA5EA9916BA240</idno>
	</analytic>
	<monogr>
		<title level="j">Trends in Pharmacological Sciences</title>
		<title level="j" type="abbrev">Trends in Pharmacological Sciences</title>
		<idno type="ISSN">0165-6147</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="407" to="413" />
			<date type="published" when="1992-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Nicotinic ?7 receptors: Synaptic options and downstream signaling in neurons</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Darwin</forename><forename type="middle">K</forename><surname>Berg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">G</forename><surname>Conroy</surname></persName>
		</author>
		<idno type="DOI">10.1002/neu.10116</idno>
		<idno type="PMID">12436416</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Neurobiology</title>
		<title level="j" type="abbrev">J. Neurobiol.</title>
		<idno type="ISSN">0022-3034</idno>
		<idno type="ISSNe">1097-4695</idno>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="512" to="523" />
			<date type="published" when="2002-11-15" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Neuronal nicotinic receptors in the human brain</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Paterson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Agneta</forename><surname>Nordberg</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0301-0082(99)00045-3</idno>
		<idno type="PMID">10759066</idno>
		<idno type="PII">S0301-0082(99)00045-3</idno>
		<idno type="ark">ark:/67375/6H6-12HDH9BL-L</idno>
		<idno type="istexId">487D33E21A1EE8C32340B328D7FD4768A1883A62</idno>
	</analytic>
	<monogr>
		<title level="j">Progress in Neurobiology</title>
		<title level="j" type="abbrev">Progress in Neurobiology</title>
		<idno type="ISSN">0301-0082</idno>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="75" to="111" />
			<date type="published" when="2000-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edward</forename><forename type="middle">D</forename><surname>Levin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">Joseph</forename><surname>Mcclernon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Amir</forename><forename type="middle">H</forename><surname>Rezvani</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00213-005-0164-7</idno>
		<idno type="PMID">16220335</idno>
		<idno type="ark">ark:/67375/VQC-K626SJ88-C</idno>
		<idno type="istexId">00144AC8E06303A176A05B095ADEED79A32C90AF</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<title level="j" type="abbrev">Psychopharmacology</title>
		<idno type="ISSN">0033-3158</idno>
		<idno type="ISSNe">1432-2072</idno>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="issue">3-4</biblScope>
			<biblScope unit="page" from="523" to="539" />
			<date type="published" when="2005-10-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer’s Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Toyohara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Hashimoto</surname></persName>
		</author>
		<idno type="DOI">10.2174/1874104501004010037</idno>
		<idno type="PMID">21249164</idno>
		<idno type="PMCID">PMC3023065</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3023065?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">The Open Medicinal Chemistry Journal</title>
		<title level="j" type="abbrev">Open Med Chem J</title>
		<idno type="ISSN">1874-1045</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="37" to="56" />
			<date type="published" when="2010-05-27" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Brain Imaging of Nicotinic Receptors in Alzheimer&apos;s Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masatomo</forename><surname>Ishikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jichun</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Hashimoto</surname></persName>
		</author>
		<idno type="DOI">10.4061/2010/548913</idno>
		<idno type="PMID">21253523</idno>
		<idno type="PMCID">PMC3022172</idno>
		<ptr type="open-access" target="http://downloads.hindawi.com/journals/ijad/2010/548913.pdf" />
	</analytic>
	<monogr>
		<title level="j">International Journal of Alzheimer&apos;s Disease</title>
		<title level="j" type="abbrev">International Journal of Alzheimer&apos;s Disease</title>
		<idno type="ISSNe">2090-0252</idno>
		<imprint>
			<biblScope unit="volume">2010</biblScope>
			<biblScope unit="page" from="1" to="11" />
			<date type="published" when="2010" />
			<publisher>Hindawi Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">α7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masatomo</forename><surname>Ishikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Hashimoto</surname></persName>
		</author>
		<idno type="DOI">10.2174/138161211795049561</idno>
		<idno type="PMID">21355839</idno>
	</analytic>
	<monogr>
		<title level="j">Current Pharmaceutical Design</title>
		<title level="j" type="abbrev">Current Pharmaceutical Design</title>
		<idno type="ISSN">1381-6128</idno>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="121" to="129" />
			<date type="published" when="2011-01-01" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">&amp;#945;7 Nicotinic Receptor Agonists as Potential Therapeutic Drugs for Schizophrenia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kaori</forename><surname>Koike</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eiji</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaomi</forename><surname>Iyo</surname></persName>
		</author>
		<idno type="DOI">10.2174/1568015054863828</idno>
	</analytic>
	<monogr>
		<title level="j">Current Medicinal Chemistry-Central Nervous System Agents</title>
		<title level="j" type="abbrev">CMCCNSA</title>
		<idno type="ISSN">1568-0150</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="171" to="184" />
			<date type="published" when="2005-09-01" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lauraf.</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Williamr.</forename><surname>Kem</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><surname>Freedman</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00213-003-1750-1</idno>
		<idno type="PMID">15205879</idno>
		<idno type="ark">ark:/67375/VQC-FQ1SXF41-X</idno>
		<idno type="istexId">349ED56BC6FBF9E84CBEA976FEF120B96DD8613E</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<title level="j" type="abbrev">Psychopharmacology</title>
		<idno type="ISSN">0033-3158</idno>
		<idno type="ISSNe">1432-2072</idno>
		<imprint>
			<biblScope unit="volume">174</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="54" to="64" />
			<date type="published" when="2004-02-19" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Treating schizophrenia symptoms with an α7 nicotinic agonist, from mice to men</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ann</forename><surname>Olincy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karen</forename><forename type="middle">E</forename><surname>Stevens</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bcp.2007.07.015</idno>
		<idno type="PMID">17714692</idno>
		<idno type="PMCID">PMC2134979</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2134979?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Biochemical Pharmacology</title>
		<title level="j" type="abbrev">Biochemical Pharmacology</title>
		<idno type="ISSN">0006-2952</idno>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1192" to="1201" />
			<date type="published" when="2007-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Allosteric modulation of nicotinic acetylcholine receptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><surname>Bertrand</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Murali</forename><surname>Gopalakrishnan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bcp.2007.07.011</idno>
		<idno type="PMID">17707779</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemical Pharmacology</title>
		<title level="j" type="abbrev">Biochemical Pharmacology</title>
		<idno type="ISSN">0006-2952</idno>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1155" to="1163" />
			<date type="published" when="2007-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Advances in the Discovery of Novel Positive Allosteric Modulators of the α7 Nicotinic Acetylcholine Receptor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ramin</forename><surname>Faghih</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gregory</forename><forename type="middle">A</forename><surname>Gfesser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Murali</forename><surname>Gopalakrishnan</surname></persName>
		</author>
		<idno type="DOI">10.2174/157488907780832751</idno>
		<idno type="PMID">18221220</idno>
	</analytic>
	<monogr>
		<title level="j">Recent Patents on CNS Drug Discovery</title>
		<title level="j" type="abbrev">RPCN</title>
		<idno type="ISSN">1574-8898</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="99" to="106" />
			<date type="published" when="2007-06-01" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Allosteric Modulators of the α7 Nicotinic Acetylcholine Receptor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ramin</forename><surname>Faghih</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Murali</forename><surname>Gopalakrishnan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Clark</forename><forename type="middle">A</forename><surname>Briggs</surname></persName>
		</author>
		<idno type="DOI">10.1021/jm070256g</idno>
		<idno type="PMID">18198823</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Medicinal Chemistry</title>
		<title level="j" type="abbrev">J. Med. Chem.</title>
		<idno type="ISSN">0022-2623</idno>
		<idno type="ISSNe">1520-4804</idno>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="701" to="712" />
			<date type="published" when="2008-02" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Preclinical Characterization of A-582941: A Novel α7 Neuronal Nicotinic Receptor Agonist with Broad Spectrum Cognition-Enhancing Properties</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karin</forename><forename type="middle">R</forename><surname>Tietje</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">J</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">Scott</forename><surname>Bitner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eric</forename><forename type="middle">A</forename><surname>Blomme</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">J</forename><surname>Brackemeyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Clark</forename><forename type="middle">A</forename><surname>Briggs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kaitlin</forename><forename type="middle">E</forename><surname>Browman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dagmar</forename><surname>Bury</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Curzon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karla</forename><forename type="middle">U</forename><surname>Drescher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jennifer</forename><forename type="middle">M</forename><surname>Frost</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ryan</forename><forename type="middle">M</forename><surname>Fryer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerard</forename><forename type="middle">B</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jens</forename><forename type="middle">Halvard</forename><surname>Gronlien</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Monika</forename><surname>Håkerud</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Earl</forename><forename type="middle">J</forename><surname>Gubbins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sabine</forename><surname>Halm</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rosalind</forename><forename type="middle">J</forename><surname>Helfrich</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kathy</forename><forename type="middle">L</forename><surname>Kohlhaas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Devalina</forename><surname>Law</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><surname>Malysz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kennan</forename><forename type="middle">C</forename><surname>Marsh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruth</forename><forename type="middle">L</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">D</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Angela</forename><forename type="middle">L</forename><surname>Molesky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Arthur</forename><forename type="middle">L</forename><surname>Nikkel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephani</forename><surname>Otte</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Liping</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pamela</forename><forename type="middle">S</forename><surname>Puttfarcken</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">J</forename><surname>Radek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Holly</forename><forename type="middle">M</forename><surname>Robb</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eva</forename><surname>Spies</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kirsten</forename><surname>Thorin-Hagene</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeffrey</forename><forename type="middle">F</forename><surname>Waring</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hilde</forename><surname>Ween</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hongyu</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Murali</forename><surname>Gopalakrishnan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">H</forename><surname>Bunnelle</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1755-5949.2008.00037.x</idno>
		<idno type="PMID">18482100</idno>
	</analytic>
	<monogr>
		<title level="j">CNS Neuroscience &amp; Therapeutics</title>
		<title level="j" type="abbrev">CNS Neurosci Therap</title>
		<idno type="ISSN">1755-5930</idno>
		<idno type="ISSNe">1755-5949</idno>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="65" to="82" />
			<date type="published" when="2008-03" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Nicotinic Receptor-Mediated Neuroprotection in Neurodegenerative Disease Models</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shun</forename><surname>Shimohama</surname></persName>
		</author>
		<idno type="DOI">10.1248/bpb.32.332</idno>
		<idno type="PMID">19252273</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/bpb/32/3/32_3_332/_pdf" />
	</analytic>
	<monogr>
		<title level="j">Biological &amp; Pharmaceutical Bulletin</title>
		<title level="j" type="abbrev">Biol. Pharm. Bull.</title>
		<idno type="ISSN">0918-6158</idno>
		<idno type="ISSNe">1347-5215</idno>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="332" to="336" />
			<date type="published" when="2009" />
			<publisher>Pharmaceutical Society of Japan</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Brain receptor imaging</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">D</forename><surname>Heiss</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Herholz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nucl Med</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="302" to="312" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">The Quest for Eldorado: Development of Radioligands for In Vivo Imaging of Nicotinic Acetylcholine Receptors in Human Brain</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">G</forename><surname>Horti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Victor</forename><forename type="middle">L</forename><surname>Villemagne</surname></persName>
		</author>
		<idno type="DOI">10.2174/138161206778559605</idno>
		<idno type="PMID">17073685</idno>
	</analytic>
	<monogr>
		<title level="j">Current Pharmaceutical Design</title>
		<title level="j" type="abbrev">CPD</title>
		<idno type="ISSN">1381-6128</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">30</biblScope>
			<biblScope unit="page" from="3877" to="3900" />
			<date type="published" when="2006-10-01" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Higher expression of α7 nicotinic acetylcholine receptors in human fetal compared to adult brain</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lena</forename><surname>Falk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Agneta</forename><surname>Nordberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Åke</forename><surname>Seiger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anders</forename><surname>Kjældgaard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ewa</forename><surname>Hellström-Lindahl</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0165-3806(03)00063-4</idno>
		<idno type="PMID">12711366</idno>
	</analytic>
	<monogr>
		<title level="j">Developmental Brain Research</title>
		<title level="j" type="abbrev">Developmental Brain Research</title>
		<idno type="ISSN">0165-3806</idno>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="151" to="160" />
			<date type="published" when="2003-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Amelia</forename><surname>Marutle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiao</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jennifer</forename><surname>Court</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Margaret</forename><surname>Piggott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mary</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elaine</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Agneta</forename><surname>Nordberg</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0891-0618(01)00117-x</idno>
		<idno type="PMID">11470559</idno>
		<idno type="PII">S0891-0618(01)00117-X</idno>
		<idno type="ark">ark:/67375/6H6-9VDPBG3Z-1</idno>
		<idno type="istexId">CABBE5E9A71AD29EAF7B49557487102D41096399</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Chemical Neuroanatomy</title>
		<title level="j" type="abbrev">Journal of Chemical Neuroanatomy</title>
		<idno type="ISSN">0891-0618</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="115" to="126" />
			<date type="published" when="2001-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Nicotinic receptor abnormalities in Alzheimer’s disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jennifer</forename><surname>Court</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carmen</forename><surname>Martin-Ruiz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Margaret</forename><surname>Piggott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dean</forename><surname>Spurden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><surname>Griffiths</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elaine</forename><surname>Perry</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0006-3223(00)01116-1</idno>
		<idno type="PMID">11230868</idno>
		<idno type="PII">S0006-3223(00)01116-1</idno>
		<idno type="ark">ark:/67375/6H6-P8JMHCM0-L</idno>
		<idno type="istexId">B617F6BFB1226BCA3603D4950A4E77D3B76A8EEA</idno>
	</analytic>
	<monogr>
		<title level="j">Biological Psychiatry</title>
		<title level="j" type="abbrev">Biological Psychiatry</title>
		<idno type="ISSN">0006-3223</idno>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="175" to="184" />
			<date type="published" when="2001-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Characterization of Iodinated Derivatives of α-Bungarotoxin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">William</forename><surname>James</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Niklaus</forename><forename type="middle">Arnold</forename><surname>Bersinger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bernard</forename><surname>Schwendimann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bernard</forename><forename type="middle">William</forename><surname>Fulpius</surname></persName>
		</author>
		<idno type="DOI">10.1515/bchm2.1980.361.2.1517</idno>
		<idno type="ark">ark:/67375/QT4-3LMQF3G1-8</idno>
		<idno type="istexId">D4239DF553A563F60F5B15C7C9BAF647C1FA611C</idno>
	</analytic>
	<monogr>
		<title level="j">Hoppe-Seyler´s Zeitschrift für physiologische Chemie</title>
		<title level="j" type="abbrev">Hoppe-Seyler´s Zeitschrift für physiologische Chemie</title>
		<idno type="ISSN">0018-4888</idno>
		<imprint>
			<biblScope unit="volume">361</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="1517" to="1524" />
			<date type="published" when="1980-01" />
			<publisher>Walter de Gruyter GmbH</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">R L</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">J</forename><surname>Hardick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ian</forename><forename type="middle">S</forename><surname>Blagbrough</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Barry</forename><forename type="middle">V L</forename><surname>Potter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Adrian</forename><forename type="middle">J</forename><surname>Wolstenholme</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><surname>Wonnacott</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0028-3908(98)00221-4</idno>
		<idno type="PMID">10340305</idno>
		<idno type="PII">S0028-3908(98)00221-4</idno>
		<idno type="ark">ark:/67375/6H6-TKNKX1F6-M</idno>
		<idno type="istexId">1344071CF3962402AF5B868BC6B2F7E56ACEBCD6</idno>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<title level="j" type="abbrev">Neuropharmacology</title>
		<idno type="ISSN">0028-3908</idno>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="679" to="690" />
			<date type="published" when="1999-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors</title>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="679" to="690" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main">Synthesis and pharmacological characterization of</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">A</forename><surname>Navarro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Zhong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">I</forename><surname>Carroll</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>125)I]iodomethyllycaconitine</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">A new ligand for the alpha7 nicotinic acetylcholine receptor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>I]iodo-Mla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Chem</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="142" to="145" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Recent Development of Radioligands for Imaging &amp;#945;7 Nicotinic Acetylcholine Receptors in the Brain</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Toyohara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Hashimoto</surname></persName>
		</author>
		<idno type="DOI">10.2174/156802610793176828</idno>
		<idno type="PMID">20583992</idno>
	</analytic>
	<monogr>
		<title level="j">Current Topics in Medicinal Chemistry</title>
		<title level="j" type="abbrev">CTMC</title>
		<idno type="ISSN">1568-0266</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="1544" to="1557" />
			<date type="published" when="2010-10-01" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping α7 nicotinic receptors by positron emission tomography</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Toyohara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Muneyuki</forename><surname>Sakata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masatomo</forename><surname>Ishikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keiichi</forename><surname>Oda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Ishii</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaomi</forename><surname>Iyo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kiichi</forename><surname>Ishiwata</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12149-009-0240-x</idno>
		<idno type="PMID">19337782</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of Nuclear Medicine</title>
		<title level="j" type="abbrev">Ann Nucl Med</title>
		<idno type="ISSN">0914-7187</idno>
		<idno type="ISSNe">1864-6433</idno>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="301" to="309" />
			<date type="published" when="2009-04-01" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Biodistribution and radiation dosimetry of the α7 nicotinic acetylcholine receptor ligand [11C]CHIBA-1001 in humans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Muneyuki</forename><surname>Sakata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Toyohara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keiichi</forename><surname>Oda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masatomo</forename><surname>Ishikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Ishii</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kiichi</forename><surname>Ishiwata</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nucmedbio.2010.09.007</idno>
		<idno type="PMID">21492793</idno>
	</analytic>
	<monogr>
		<title level="j">Nuclear Medicine and Biology</title>
		<title level="j" type="abbrev">Nuclear Medicine and Biology</title>
		<idno type="ISSN">0969-8051</idno>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="443" to="448" />
			<date type="published" when="2011-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">[11C]CHIBA-1001 as a Novel PET Ligand for α7 Nicotinic Receptors in the Brain: A PET Study in Conscious Monkeys</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shingo</forename><surname>Nishiyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroyuki</forename><surname>Ohba</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaaki</forename><surname>Matsuo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tatsuhiko</forename><surname>Kobashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Makoto</forename><surname>Takahagi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaomi</forename><surname>Iyo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeru</forename><surname>Kitashoji</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hideo</forename><surname>Tsukada</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0003231</idno>
		<idno type="PMID">18800169</idno>
		<idno type="PMCID">PMC2529405</idno>
		<idno>11 C]CHIBA-1001</idno>
		<ptr type="open-access" target="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0003231&amp;type=printable" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">e3231</biblScope>
			<date type="published" when="2008-09-18" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">M</forename><surname>Spencer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">J</forename><surname>Mcclellan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drugs</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="1297" to="1315" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">A review of its pharmacology and preliminary clinical findings in novel applications</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">I</forename><surname>Wilde</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Markham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Ondansetron</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drugs</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="773" to="794" />
			<date type="published" when="1996" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<monogr>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">■</forename><surname>Acknowledgments</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Ondansetron: A Selective 5-HT3 Receptor Antagonist and Its Applications in CNS-Related Disorders</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jiang-Hong</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rex</forename><surname>Ponnudurai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rebecca</forename><surname>Schaefer</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1527-3458.2001.tb00195.x</idno>
	</analytic>
	<monogr>
		<title level="j">CNS Drug Reviews</title>
		<idno type="ISSN">1080-563X</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="199" to="213" />
			<date type="published" when="2006-06-07" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The 5-HT 3 antagonist tropisetron (ICS 205-930) is a potent and selective α7 nicotinic receptor partial agonist</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">E</forename><surname>Macor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Gurley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><surname>Lanthorn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">James</forename><surname>Loch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">A</forename><surname>Mack</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><surname>Mullen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Oahn</forename><surname>Tran</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicole</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">C</forename><surname>Gordon</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0960-894x(00)00670-3</idno>
		<idno type="PMID">11212100</idno>
		<idno type="PII">S0960-894X(00)00670-3</idno>
		<idno type="ark">ark:/67375/6H6-HL3QZ3PT-7</idno>
		<idno type="istexId">7596B16DB6D484E77EA36FC280E8068E9DB76988</idno>
	</analytic>
	<monogr>
		<title level="j">Bioorganic &amp; Medicinal Chemistry Letters</title>
		<title level="j" type="abbrev">Bioorganic &amp; Medicinal Chemistry Letters</title>
		<idno type="ISSN">0960-894X</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="319" to="321" />
			<date type="published" when="2001-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Activity of α7-selective agonists at nicotinic and serotonin 5HT3 receptors expressed in Xenopus oocytes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">L</forename><surname>Papke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Julia</forename><forename type="middle">K</forename><surname>Porter Papke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">M</forename><surname>Rose</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bmcl.2003.09.104</idno>
		<idno type="PMID">15050614</idno>
	</analytic>
	<monogr>
		<title level="j">Bioorganic &amp; Medicinal Chemistry Letters</title>
		<title level="j" type="abbrev">Bioorganic &amp; Medicinal Chemistry Letters</title>
		<idno type="ISSN">0960-894X</idno>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1849" to="1853" />
			<date type="published" when="2004-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Phase I study of tropisetron capsules in healthy volunteers. Single administration</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Nomiyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Masuda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Nakajima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Aizawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Morikawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kiso to Rinsho</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1523" to="1559" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
	<note>In Japanese</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Phase I study of ondansetron (the 2nd report) -Single intravenous dose study and continuous drip infusion dose study in healthy volunteers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Kumagai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Nakashima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kotegawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Shiga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Ohira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Oribe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rinsyou-Iyaku</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1495" to="1504" />
			<date type="published" when="1992" />
		</imprint>
	</monogr>
	<note>In Japanese</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Performance evaluation of a large axial field-of-view PET scanner: SET-2400W</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takehiko</forename><surname>Fujiwara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shoichi</forename><surname>Watanuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Seiichi</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masayasu</forename><surname>Miyake</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shinya</forename><surname>Seo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masatoshi</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keizou</forename><surname>Ishii</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hikonojyou</forename><surname>Orihara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroshi</forename><surname>Fukuda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomohiko</forename><surname>Satoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keishi</forename><surname>Kitamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazumi</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shigekazu</forename><surname>Takahashi</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf03165298</idno>
		<idno type="PMID">9460522</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of Nuclear Medicine</title>
		<title level="j" type="abbrev">Ann Nucl Med</title>
		<idno type="ISSN">0914-7187</idno>
		<idno type="ISSNe">1864-6433</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="307" to="313" />
			<date type="published" when="1997-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jean</forename><surname>Logan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joanna</forename><forename type="middle">S</forename><surname>Fowler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nora</forename><forename type="middle">D</forename><surname>Volkow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gene-Jack</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu-Shin</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">L</forename><surname>Alexoff</surname></persName>
		</author>
		<idno type="DOI">10.1097/00004647-199609000-00008</idno>
		<idno type="PMID">8784228</idno>
		<ptr type="open-access" target="https://journals.sagepub.com/doi/pdf/10.1097/00004647-199609000-00008" />
	</analytic>
	<monogr>
		<title level="j">Journal of Cerebral Blood Flow &amp; Metabolism</title>
		<title level="j" type="abbrev">J Cereb Blood Flow Metab</title>
		<idno type="ISSN">0271-678X</idno>
		<idno type="ISSNe">1559-7016</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="834" to="840" />
			<date type="published" when="1996-09" />
			<publisher>SAGE Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Modified Regression Model for the Logan Plot</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">József</forename><surname>Varga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zsolt</forename><surname>Szabo</surname></persName>
		</author>
		<idno type="DOI">10.1097/00004647-200202000-00012</idno>
		<idno type="PMID">11823722</idno>
		<idno type="PMCID">PMC2012949</idno>
		<ptr type="open-access" target="http://journals.sagepub.com/doi/pdf/10.1097/00004647-200202000-00012" />
	</analytic>
	<monogr>
		<title level="j">Journal of Cerebral Blood Flow &amp; Metabolism</title>
		<title level="j" type="abbrev">J Cereb Blood Flow Metab</title>
		<idno type="ISSN">0271-678X</idno>
		<idno type="ISSNe">1559-7016</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="240" to="244" />
			<date type="published" when="2002-02" />
			<publisher>SAGE Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Characterization of [3H]CHIBA-1001 binding to α7 nicotinic acetylcholine receptors in the brain from rat, monkey, and human</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuko</forename><surname>Tanibuchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Toyohara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuko</forename><surname>Fujita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaomi</forename><surname>Iyo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Hashimoto</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.brainres.2010.06.008</idno>
		<idno type="PMID">20537987</idno>
	</analytic>
	<monogr>
		<title level="j">Brain Research</title>
		<title level="j" type="abbrev">Brain Research</title>
		<idno type="ISSN">0006-8993</idno>
		<imprint>
			<biblScope unit="volume">1348</biblScope>
			<biblScope unit="page" from="200" to="208" />
			<date type="published" when="2010-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>Characterization of</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">-1001 binding to alpha7 nicotinic acetylcholine receptors in the brain from rat, monkey, and human</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H]</forename><surname>Chiba</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">1348</biblScope>
			<biblScope unit="page" from="200" to="208" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of α7 nicotinic acetylcholine receptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaomi</forename><surname>Iyo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><surname>Freedman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karen</forename><forename type="middle">E</forename><surname>Stevens</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00213-005-0142-0</idno>
		<idno type="PMID">16136299</idno>
		<idno type="ark">ark:/67375/VQC-WFPP95DK-T</idno>
		<idno type="istexId">9BA5A2D8BAB30A998A2936E2FB1ED689C8DB97E1</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<title level="j" type="abbrev">Psychopharmacology</title>
		<idno type="ISSN">0033-3158</idno>
		<idno type="ISSNe">1432-2072</idno>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="13" to="19" />
			<date type="published" when="2005-08-31" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: Role of α7 nicotinic receptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuko</forename><surname>Fujita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tamaki</forename><surname>Ishima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroko</forename><surname>Hagiwara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaomi</forename><surname>Iyo</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejphar.2006.09.055</idno>
		<idno type="PMID">17094961</idno>
	</analytic>
	<monogr>
		<title level="j">European Journal of Pharmacology</title>
		<title level="j" type="abbrev">European Journal of Pharmacology</title>
		<idno type="ISSN">0014-2999</idno>
		<imprint>
			<biblScope unit="volume">553</biblScope>
			<biblScope unit="issue">1-3</biblScope>
			<biblScope unit="page" from="191" to="195" />
			<date type="published" when="2006-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Tropisetron improves deficits in auditory P50 suppression in schizophrenia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kaori</forename><surname>Koike</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nobuyuki</forename><surname>Takai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eiji</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naoya</forename><surname>Komatsu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroyuki</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michiko</forename><surname>Nakazato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naoe</forename><surname>Okamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karen</forename><forename type="middle">E</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><surname>Freedman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaomi</forename><surname>Iyo</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.schres.2004.12.016</idno>
		<idno type="PMID">15927799</idno>
	</analytic>
	<monogr>
		<title level="j">Schizophrenia Research</title>
		<title level="j" type="abbrev">Schizophrenia Research</title>
		<idno type="ISSN">0920-9964</idno>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="67" to="72" />
			<date type="published" when="2005-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Akihiro</forename><surname>Shiina</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yukihiko</forename><surname>Shirayama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomihisa</forename><surname>Niitsu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tasuku</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Taisuke</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tadashi</forename><surname>Hasegawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tadashi</forename><surname>Haraguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nobuhisa</forename><surname>Kanahara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsuya</forename><surname>Shiraishi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mihisa</forename><surname>Fujisaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Goro</forename><surname>Fukami</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michiko</forename><surname>Nakazato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaomi</forename><surname>Iyo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Hashimoto</surname></persName>
		</author>
		<idno type="DOI">10.1186/1744-859x-9-27</idno>
		<idno type="PMID">20573264</idno>
		<idno type="PMCID">PMC2901366</idno>
		<ptr type="open-access" target="https://annals-general-psychiatry.biomedcentral.com/track/pdf/10.1186/1744-859X-9-27" />
	</analytic>
	<monogr>
		<title level="j">Annals of General Psychiatry</title>
		<title level="j" type="abbrev">Ann Gen Psychiatry</title>
		<idno type="ISSN">1744-859X</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">27</biblScope>
			<date type="published" when="2010" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
